{"podcast":{"title":"Outcomes Rocket","slug":"outcomes-rocket-769427","podcast_index_feed_id":769427,"rss_url":"https://feeds.megaphone.fm/NSSMO9468790350","website_url":"https://outcomesrocket.com","image_url":"https://megaphone.imgix.net/podcasts/d6a2bca6-5647-11ed-835d-8324f12a40ac/image/OR_New_Cover_12.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"Saul Marquez","episode_count":2258,"summary":"At Outcomes Rocket, we are the shared knowledge hub for healthcare's toughest problems. Our goal is twofold and clear. To help inspire and guide our listeners to 1. Improve patient outcomes and 2. Experience business success in healthcare. Tune in to learn more!","last_synced_at":"2026-07-21T22:21:07.001965+00:00","page_url":"https://stenobird.com/podcast/outcomes-rocket-769427"},"episode":{"title":"From Blind Biopsies to Precision: Reinventing Medical Imaging with  Reza Khorasaninejad, Founder & CEO at LEADOPTIK","slug":"from-blind-biopsies-to-precision-reinventing-medical-imaging-with-reza-khorasaninejad-founder-ceo-at-leadoptik","published_at":"2026-06-22T10:00:00+00:00","page_url":"https://stenobird.com/podcast/outcomes-rocket-769427/from-blind-biopsies-to-precision-reinventing-medical-imaging-with-reza-khorasaninejad-founder-ceo-at-leadoptik","show_page_url":"https://stenobird.com/podcast/outcomes-rocket-769427","url":"https://pfx.vpixl.com/00edT/traffic.megaphone.fm/NSSMO5860151988.mp3","audio_url":"https://pfx.vpixl.com/00edT/traffic.megaphone.fm/NSSMO5860151988.mp3","summary":"Lung cancer biopsies are still being done blind more often than you’d think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Founder & CEO at LEADOPTIK, discusses how advances in photonics and metasurface engineering are enabling highly miniaturized imaging systems for minimally invasive procedures. These innovations aim to address a major challenge in lung cancer biopsies: a lack of imaging guidance that can lead to significant diagnostic errors. Early clinical pilots across multiple sites are demonstrating strong performance, with one hospital already converting into a paying customer. Looking ahead, the company is partnering with Stanford Medicine to develop AI-driven decision support tools to further improve diagnostic accuracy. Tune in to learn how next-generation imaging and AI are changing that reality and helping physicians hit the right target the first time! Resources: Connect with and follow Reza Khorasaninejad on LinkedIn.Follow LEADOPTIK on LinkedIn and explore their website!","meta_description":"Lung cancer biopsies are still being done blind more often than you’d think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Fo…","key_points":[],"chapters":[],"topics":[],"duration_seconds":749,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/outcomes-rocket-769427/episodes/from-blind-biopsies-to-precision-reinventing-medical-imaging-with-reza-khorasaninejad-founder-ceo-at-leadoptik/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/outcomes-rocket-769427/from-blind-biopsies-to-precision-reinventing-medical-imaging-with-reza-khorasaninejad-founder-ceo-at-leadoptik.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}